Showing results (141-150 of 258) with videos related to
Sort By:
Pageof 26
Cancer Medicine|December 10, 2015
Intravenous high-dose interferon with or without maintenance treatment in melanoma at high risk of recurrence: meta-analysis of three trialsAgnieszka Malczewski, Andrea Marshall, Miranda J Payne, et al.Cancer Investigation|September 18, 2008
Gemcitabine combined with gefitinib in patients with inoperable or metastatic pancreatic cancer: a phase II Study of the Hellenic Cooperative Oncology Group with biomarker evaluationGeorge Fountzilas, Mattheos Bobos, Anna Kalogera-Fountzila, et al.Plos One|January 30, 2014
A new mathematical model for the interpretation of translational research evaluating six CTLA-4 polymorphisms in high-risk melanoma patients receiving adjuvant interferonPetr Pancoska, John M Kirkwood, Spyros Bouros, et al.Cancer|June 16, 2010
Correlation of molecular human leukocyte antigen typing and outcome in high-risk melanoma patients receiving adjuvant interferonHelen Gogas, John M Kirkwood, Christine S Falk, et al.Plos One|August 17, 2013
Identification and validation of a multigene predictor of recurrence in primary laryngeal cancerElena Fountzilas, Vassiliki Kotoula, Nikolaos Angouridakis, et al.European Journal of Haematology|May 19, 2010
High serum lactate dehydrogenase adds prognostic value to the international myeloma staging system even in the era of novel agentsEvangelos Terpos, Eirini Katodritou, Maria Roussou, et al.Clinical Breast Cancer|May 26, 2010
Paclitaxel and carboplatin as neoadjuvant chemotherapy in patients with locally advanced breast cancer: A phase II Trial of the Hellenic Cooperative Oncology GroupHelen Gogas, Dimitrios Pectasides, Ioannis Kostopoulos, et al.Anticancer Research|January 4, 2012
Vinorelbine versus paclitaxel for patients with advanced non-small cell lung cancer (NSCLC) and a performance status of 2Paris A Kosmidis, Konstantinos Syrigos, Haralampos P Kalofonos, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Gemcitabine versus gemcitabine-carboplatin for patients with advanced non-small cell lung cancer and a performance status of 2: a prospective randomized phase II study of the Hellenic Cooperative Oncology GroupParis A Kosmidis, Meletios-Athanasios Dimopoulos, Konstantinos Syrigos, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|November 16, 2016
Sequencing Treatment in BRAFV600 Mutant Melanoma: Anti-PD-1 Before and After BRAF InhibitionDouglas B Johnson, Eirini Pectasides, Emily Feld, et al.Pageof 26